Brief: Prolight Diagnostics Announces Positive Pre-Clinical Validation Study Results
31/03/2025 08:12
March 31 (Reuters) - Prolight Diagnostics AB (publ) PRLD.NGM: ANNOUNCES POSITIVE PRE-CLINICAL VALIDATION STUDY RESULTS Source text: ID:nMFNblfQdb Further company coverage: PRLD.NGM (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Prolight Diagnostics AB (publ)
See all newsBrief: Prolight's Rights Issue Was Fully Subscribed
Brief: Prolight Diagnostics Announces Positive Pre-Clinical Validation Study Results
Brief: Prolight Announces Positive Results From Study With Biobank Plasma Samples
Brief: Prolight Gets SEK 17 Mln UK Government Grant In Collaboration With Leading UK Hospital Trust
Brief: Prolight Diagnostics Q3 Loss After Tax Widens To SEK 1.9 Mln